Peroxisome proliferator-activated receptors as therapeutic targets in inflammation

Publisher： Elsevier

ISSN： 0735-1097

Source： Journal of the American College of Cardiology, Vol.42, Iss.10, 2003-11, pp. : 1764-1766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease

By Azhar Salman

Future Cardiology, Vol. 6, Iss. 5, 2010-09 ,pp. : 657-691

Future Medicine

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju Lee Yong Chul

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Functional Genetic Variants of PPARγ and PPARα Encoding Peroxisome Proliferator-Activated Receptors and Susceptibility to Ischemic Stroke in Chinese Han Population

Cerebrovascular Diseases, Vol. 41, Iss. 1-2, 2016-0 ,pp. : 96-99

Karger

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor- in macrophage lipid homeostasis

By Lee C.-H. Evans R.M.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 8, 2002-10 ,pp. : 331-335

Elsevier

Access to resources Recommend Favorite

Polymorphism in the peroxisome proliferator‐activated receptor‐ gene in women with polycystic ovary syndrome

By Korhonen S.

Human Reproduction, Vol. 18, Iss. 3, 2003-03 ,pp. : 540-543

Oxford University Press

Access to resources Recommend Favorite